Content about Middle age

January 8, 2013
ERSP requests Casper Labs to tone down marketing message behind supplement Calmestra

The Electronic Retailing Self-Regulation Program recommended that Casper Labs modify or discontinue certain claims for Calmestra, a dietary supplement marketed as providing relief for symptoms of menopause, including claims that the product has been “clinically proven” to address symptoms of menopause.

NEW YORK — The Electronic Retailing Self-Regulation Program on Tuesday recommended that Casper Labs modify or discontinue certain claims for Calmestra, a dietary supplement marketed as providing relief for symptoms of menopause, including claims that the product has been “clinically proven” to address symptoms of menopause.

September 21, 2012
Poise brand launches comedy road show to get women talking about menopause

Comedic actresses Sherri Shepherd and Cloris Leachman are finding the humor in menopause by headlining the Poise brand’s Hot Flash Road Show, a free comedy tour making stops in New York and Los Angeles this fall that was announced Friday by Kimberly Clark.

DALLAS  — Comedic actresses Sherri Shepherd and Cloris Leachman are finding the humor in menopause by headlining the Poise brand’s Hot Flash Road Show, a free comedy tour making stops in New York and Los Angeles this fall that was announced Friday by Kimberly Clark. Open to the public, the Hot Flash Road Show is part of The 2nd Talk, an effort led by the Poise brand to start a whole new way to talk about menopause and help women approach this life stage with confidence.

June 29, 2012
FDA accepts application for Shionogi VVA treatment

The Food and Drug Administration has accepted a regulatory approval application for a drug made by Shionogi for treating vulvar and vaginal atrophy due to menopause.

FLORHAM PARK, N.J. — The Food and Drug Administration has accepted a regulatory approval application for a drug made by Shionogi for treating vulvar and vaginal atrophy due to menopause.

Shionogi, the U.S. division of Japanese drug maker Shionogi & Co., said Wednesday that the FDA had accepted for review its application for ospemifene, which the company touts as potentially the first oral alternative to vaginal estrogen treatments.

August 10, 2011
Study: Soy supplementation ineffective versus relief of menopausal symptoms

Soy isoflavone tablets do not appear to be associated with a reduction in bone loss or menopausal symptoms in women within the first five years of menopause, according to a report in the Aug. 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

MIAMI — Soy isoflavone tablets do not appear to be associated with a reduction in bone loss or menopausal symptoms in women within the first five years of menopause, according to a report in the Aug. 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

September 6, 2010
Bayer Consumer Care adds two products to One A Day line

Bayer Consumer Care on Tuesday introduced two new gender-specific multivitamins: One A Day Menopause Formula...

MORRISTOWN, N.J. Bayer Consumer Care on Tuesday introduced two new gender-specific multivitamins: One A Day Menopause Formula and One A Day Men’s Pro Edge.

 

One A Day Menopause Formula is a complete multivitamin formulated with soy isoflavones to help address hot flashes and mild mood changes.

 

May 17, 2010
Teva: Enjuvia may reduce nighttime awakenings in postmenopausal women

A branded drug made by Teva Pharmaceutical Industries reduced the frequency of nighttime awakenings due...

March 2, 2010
Vichy's Neovadiol Gf arriving at CVS, Duane Reade

Launching for spring 2010 at CVS/pharmacy and Duane Reade are the new Neovadiol Gf Day...